Do analysts agree on adiCET bio's (ACET) price targets?
The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings. According to analysts' consensus price target of $32.60, Adicet Bio has a forecasted upside of 156.9% from its current price of $12.69.
Where can I buy ACET shares?
Shares of ACET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Who owns adiCET bio?
The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA. What Type Of Shareholders Make Up Adicet Bio, Inc.'s (NASDAQ:ACET) Share Registry?
Should I buy ACET stock?
The consensus among 5 Wall Street analysts covering (NASDAQ: ACET) stock is to Strong Buy ACET stock.
Is Adicet bio a good investment?
The 10 analysts offering 12-month price forecasts for Adicet Bio Inc have a median target of 28.00, with a high estimate of 35.00 and a low estimate of 21.00. The median estimate represents a +59.18% increase from the last price of 17.59.
Is ACET stock a buy right now?
7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Adicet Bio in the last twelve months. There are currently 7 buy r...
Will Adicet Bio's stock price go up in 2022?
7 brokers have issued 12-month price targets for Adicet Bio's stock. Their forecasts range from $21.00 to $34.00. On average, they expect Adicet Bi...
How has Adicet Bio's stock price performed in 2022?
Adicet Bio's stock was trading at $17.49 on January 1st, 2022. Since then, ACET stock has decreased by 24.5% and is now trading at $13.21. View th...
Are investors shorting Adicet Bio?
Adicet Bio saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 3,040,000 shares, an increas...
When is Adicet Bio's next earnings date?
Adicet Bio is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast for Adicet B...
How were Adicet Bio's earnings last quarter?
Adicet Bio, Inc. (NASDAQ:ACET) issued its quarterly earnings data on Thursday, May, 12th. The company reported $0.10 earnings per share for the qua...
Who are Adicet Bio's key executives?
Adicet Bio's management team includes the following people: Mr. Chen Schor BA , CPA, CPA, M.B.A., MBA, CEO, Pres & Director (Age 50, Pay $866.77...
Who are some of Adicet Bio's key competitors?
Some companies that are related to Adicet Bio include Fastenal (FAST) , W.W. Grainger (GWW) , United Rentals (URI) , Watsco (WSO) , WESCO Inte...
What other stocks do shareholders of Adicet Bio own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Adicet Bio investors own include Marin Software (MRIN) ,...
About Adicet Bio
Headlines
Adicet Bio, Inc. is a biotechnology company, which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Adicet Bio (NASDAQ:ACET) Frequently Asked Questions
What Type Of Shareholders Make Up Adicet Bio, Inc.'s (NASDAQ:ACET) Share Registry?
Signals & Forecast
5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Adicet Bio in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Adicet Bio stock. View analyst ratings for Adicet Bio or view top-rated stocks.
Support, Risk & Stop-loss
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Adicet Bio Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock.
Is Adicet Bio Inc stock A Buy?
Adicet Bio Inc finds support from accumulated volume at $13.57 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Insiders are very negative
The Adicet Bio Inc stock holds several negative signals and despite the positive trend, we believe Adicet Bio Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
About Adicet Bio Inc
In the last 1 trades there were . The last trade was done 19 046 days ago by who bough 0 shares.
Golden Star Signal
Aceto Corporation, together with its subsidiaries, sources, markets, sells, and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products, and specialty chemicals.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
What time do you trade in the pre market?
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
What is Adicet Bio Inc?
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Stock prices may also move more quickly in this environment.
Does market cap include convertible securities?
Adicet Bio Inc is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.
Adicet Bio (NASDAQ:ACET) Price Target and Consensus Rating
It does not include securities convertible into the common equity securities. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable).
Analyst Ratings By Month
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).
Average Share Price and Price Target by Month
The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Adicet Bio (NASDAQ:ACET) Analyst Ratings Frequently Asked Questions
The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target.